BloomIntegrated Health
BloomIntegrated Health

Communications Medicine, July 2026

"75% of participants were in remission"

The first U.S. pilot trial of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD.

Psychedelic medicine is happening

Psychedelic Therapy - Bloom Integrated Health

Right now.

In July 2026, Eli Lilly — one of the largest pharmaceutical companies in the world — agreed to pay up to $3.8 billion for AtaiBeckley, whose lead candidate is a patented, DMT-based drug formulation — the largest deal the psychedelic-medicine sector has ever seen.[16]

It follows AbbVie's $1.2 billion acquisition in the same space less than a year earlier.

Big pharma only moves money like that on positive scientific evidence, and that evidence has been building for years.

Bloom Integrated Health founder Dr. Angela Fisher is a national leader in legal psychedelic-assisted therapy. She was among the first health practitioners in the U.S. to offer sanctioned psilocybin and MDMA therapy through her Native American Indigenous Church, Sacred Bloom.

"Antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last a year."
— Gukasyan, Davis, et al, 2022, Journal of Psychopharmacology

So what's 'supportive psychotherapy'?

That's where we come in, deeply informed &. experienced in the preparation that gets you ready, and the integration that turns an experience into change you can actually keep. This is both clinical and community work to be done for individuals at Bloom Integrated Health— and where a great deal of lasting difference is made.

The Sacred Bloom Church Collective enables guided psychedelic sessions to happen in a clinical context where prescribed, and these sessions are supported through the same structure researchers actually use.

In clinical psilocybin trials — including COMPASS Pathways' own published model[17] — this isn't formal talk therapy. It's structured psychological support built in three phases: preparation sessions to build trust and set intentions, quiet, non-directive presence during the guided experience itself, and integration sessions afterward to work through what surfaced.

About the sacramental work

The ceremonial & formal medicinal use of psychedelic medicines is enabled under the auspices of the Sacred Bloom Church Collective, a Native American religious community dedicated to spiritual growth, and guidelines established by the Religious Freedom Restoration Act of 1993.

On its own, psilocybin is Schedule I in Florida, so that's a no. The sacramental path is a specific, tested legal framework, not a blanket permission. Read our psilocybin explainer.

So where do I start?

Everything we do starts with a conversation.

Whatever you want to ask — whether this is right for you, what a session is actually like, which medicines may be right. Call 727-490-9911 or click below to schedule your evaluation.

The evaluation is a full medical review, and it is the reason we can say yes to anyone at all. Psychedelics are not safe for everyone: a personal or family history of psychosis, schizophrenia or bipolar disorder; cardiovascular or respiratory conditions; pregnancy or breastfeeding; active substance-use issues; and a number of psychiatric medications — antidepressants especially — can each make someone an unsuitable candidate. We would far rather find that out with you at the beginning than have you find it out during a session.

Sacred Bloom Church Collective - Bloom Integrated Health

Find out more

All retreats and individual sessions reserved for members of the Sacred Bloom Church Collective. Membership starts with a conversation. Book a call to find out if membership is right for you.

Skye ReyesBook
Initial ConsultationFLIN
Ethan Owens, ASDCSBook
Initial ConsultationFLIN
Ella WatersBook
Initial ConsultationFLIN
Donna OnjalaBook
Initial ConsultationFLGA

Psychedelic Practitioners

Kat Silver, MA
Celeste Verastequi
Erica Veno, MSW
Sarah Albrecht, MS
Ethan Owens, ASDCS
Maggie O’Connell, ANRP
Donna Onjala
Angela Fisher, PhD
Sources
  1. [1] Exec. Order 14401 (Apr 18, 2026) — directs agencies to fast-track psychedelic therapies and review rescheduling. ↩
  2. [2] FDA psychedelic priority-review vouchers (2026): Compass (psilocybin/TRD), Usona (psilocybin/MDD), Otsuka (methylone/PTSD). ↩
  3. [3] HHS Secretary public statements supporting legal psychedelic access for veterans. ↩
  4. [4] Compass Pathways COMP360 psilocybin, Phase 3 (COMP005, 2025; COMP006, 2026), treatment-resistant depression. ↩
  5. [5] MDMA-assisted therapy for PTSD, Phase 3 (MAPS/Lykos), Nature Medicine (2021; 2023). ↩
  6. [6] Johns Hopkins Center for Psychedelic & Consciousness Research — psilocybin for depression, end-of-life distress. ↩
  7. [7] U.S. Dept. of Veterans Affairs — first VA-funded psychedelic trials in ~50 years (psilocybin, MDMA). ↩
  8. [8] DoD / NDAA-funded active-duty psychedelic research. ↩
  9. [9] Texas SB 2308 — $50M ibogaine consortium; Stanford ibogaine/TBI veteran study, Nature Medicine (2024). ↩
  10. [10] RFRA, 42 U.S.C. §2000bb; Gonzales v. O Centro, 546 U.S. 418 (2006) — 8–0, sacramental psychedelic use protected. ↩
  11. [11] AIRFA; NAC peyote exemption, 42 U.S.C. §1996a. ↩
  12. [12] Recent federal RFRA exemptions for entheogenic churches (e.g., Church of the Eagle and the Condor, 2024). ↩
  13. [13] Fla. Stat. §893.03/§893.13 & SB 700 (2025, spores) — baseline the church frame operates against. ↩
  14. [14] State programs: Oregon (M109), Colorado (Prop 122), New Mexico Medical Psilocybin Act (2025). State-legal only; federally Schedule I. ↩
  15. [15] Gukasyan, Davis, et al, 2022 Journal of Psychopharmacology ↩
  16. [16] Forbes 7/20/2026 "Eli Lilly/AtaiBeckley, $2.8B upfront..." ↩
  17. [17] Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions ↩